What exactly did Jefferies do for Ingevity on February 26, 2026?

Jefferies maintained a **Buy** rating on Ingevity and raised the price target to **$82** on February 26, 2026. The action kept the same rating but increased the expected upside based on updated financial assumptions.

How should I interpret the NGVT analyst rating change for my portfolio?

A maintained Buy with a higher PT signals confidence in future earnings without a change in conviction. Use the NGVT analyst rating as a favorable input, but weigh it with guidance, valuation, and your risk tolerance.

Where can I read the analyst note and recent earnings details cited here?

Jefferies’ price target update is summarized on StreetInsider and the Q4 2025 earnings call transcript is on Seeking Alpha. Use both for primary detail and modelling inputs [source](https://www.streetinsider.com/Analyst+Comments/Ingevity+Corp+%28NGVT%29+PT+Raised+to+%2482+at+Jefferies/26069301.html)

Analyst Ratings

Jefferies Maintains Buy on Ingevity (NGVT) Feb 2026; PT Raised to $82

ByDanny Kontos March 2, 2026March 2, 2026

NGVT analyst rating: Jefferies maintained a Buy on Ingevity Corporation and lifted the price target to $82 on February 26, 2026. This action keeps Jefferies’ positive stance while signaling confidence after Ingevity’s recent Q4 2025 results and 2026 guidance. Investors should note the maintained Buy came with an updated target, not a new conviction or a downgrade.